Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Alosetron. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A known ✓ | P46098 | 3/20 | 0.81 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.81 |
| ▸ | HTR2B | P41595 | 2/20 | 0.81 |
| ▸ | HTR2A | P28223 | 2/20 | 0.81 |
| ▸ | HTR2C | P28335 | 2/20 | 0.81 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.81 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.81 |
| ▸ | CASP6 | P55212 | 1/20 | 0.80 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.39 |
| ▸ | HTR3B | O95264 | 2/20 | 0.39 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.39 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.39 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alosetron SCHEMBL13345850 | 0.94 | KCNH2 (0.72) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL29377019 | 0.90 | KCNH2 (1.00) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL631 | 0.90 | KCNH2 (1.00) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL806 | 0.89 | CASP6 (1.00) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL29387635 | 0.89 | CASP6 (1.00) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL635233 | 0.88 | KCNH2 (0.96) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL13345840 | 0.87 | KCNH2 (0.67) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL850 | 0.85 | KCNH2 (0.90) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL13345803 | 0.85 | KCNH2 (0.60) | KCNH2HTR3ACYP3A4CYP1A2HTR2B | |
| Alosetron SCHEMBL13345838 | 0.85 | KCNH2 (0.86) | KCNH2HTR3ACYP3A4CYP1A2HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100113478-A1 | INDOLONE MODULATORS OF 5-HT3 RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113478-A1 | INDOLONE MODULATORS OF 5-HT3 RECEPTOR | HTR3A, HTR3B, HTR3E | HTR3A 1/4885KCNH2 1673/4885CYP3A4 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.